159 related articles for article (PubMed ID: 37209888)
1. Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
Grover S; Seckar T; Gao L; Bhatia R; Lin X; Zetola N; Ramogola-Masire D; Robertson E
Tumour Virus Res; 2023 Jun; 15():200262. PubMed ID: 37209888
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa.
Chachage M; Parikh AP; Mahenge A; Bahemana E; Mnkai J; Mbuya W; Mcharo R; Maganga L; Mwamwaja J; Gervas R; Kibuuka H; Maswai J; Singoei V; Iroezindu M; Fasina A; Esber A; Dear N; Imbach M; Crowell TA; Hern J; Song X; Hoelscher M; Polyak CS; Ake JA; Geldmacher C;
AIDS; 2023 Mar; 37(4):625-635. PubMed ID: 36398743
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya.
Tawe L; Choga WT; Paganotti GM; Bareng OT; Ntereke TD; Ramatlho P; Ditshwanelo D; Gaseitsiwe S; Kasvosve I; Ramogola-Masire D; Orang'o OE; Robertson E; Zetola N; Moyo S; Grover S; Ermel AC
BMC Infect Dis; 2022 Jan; 22(1):95. PubMed ID: 35086475
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S
Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
[TBL] [Abstract][Full Text] [Related]
6. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
[TBL] [Abstract][Full Text] [Related]
7. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study.
Gilles C; Rozenberg S; Buxant F; Manigart Y; de Wind R; Houte KV; Vandenbroeck D; Delforge M; Konopnicki D
Vaccine; 2022 Nov; 40(50):7230-7237. PubMed ID: 36328880
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
[TBL] [Abstract][Full Text] [Related]
9. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
Metz CK; Skof AS; Sehouli J; Siedentopf JP; Gebert P; Weiss F; Alba Alejandre I; Heinrich-Rohr M; Weizsaecker K; Henrich W; Kaufmann AM; Rohr I
Arch Gynecol Obstet; 2023 Jul; 308(1):207-218. PubMed ID: 36576558
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.
Macleod IJ; O'Donnell B; Moyo S; Lockman S; Shapiro RL; Kayembe M; van Widenfelt E; Makhema J; Essex M; Wester C
J Med Virol; 2011 Oct; 83(10):1689-95. PubMed ID: 21837784
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
[TBL] [Abstract][Full Text] [Related]
12. Progress and challenges in human papillomavirus and cervical cancer in southern Africa.
Ramogola-Masire D; Luckett R; Dreyer G
Curr Opin Infect Dis; 2022 Feb; 35(1):49-54. PubMed ID: 34873079
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus prevalence among unvaccinated young female college students in Botswana: A cross-sectional study.
Ramatlho P; Grover S; Mathoma A; Tawe L; Matlhagela K; Ngoni K; Molebatsi K; Chilisa B; Zetola NM; Robertson ES; Paganotti GM; Ramogola-Masire D
S Afr Med J; 2022 Apr; 112(5):335-340. PubMed ID: 35587246
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the association between smoking exposure and HPV-related cervical cell abnormality among women living with HIV: Implications for prevention strategies.
Zhao R; Sekar P; Bennis SL; Kulasingam S
Prev Med; 2023 May; 170():107494. PubMed ID: 37001607
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
[TBL] [Abstract][Full Text] [Related]
16. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
19. Veteran Women Living With Human Immunodeficiency Virus Have Increased Risk of Human Papillomavirus (HPV)-Associated Genital Tract Cancers.
Clark E; Chen L; Dong Y; Raychaudhury S; White D; Kramer JR; Chiao E
Clin Infect Dis; 2021 May; 72(9):e359-e366. PubMed ID: 32785700
[TBL] [Abstract][Full Text] [Related]
20. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
